Second, the thematically related genes we continually identified across our genomic assays have ties to known AP-1-regulated genes and therefore AP-1 may be a good candidate to investigate as a new target in rhabdoid cancers, particularly as it relates to migration and angiogenic tumor functions. This evidence concerns the gene JUN and neoplasm.